Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track VIVS with free AI briefings, catalyst countdowns, and dilution alerts.

VIVS · VivoSim Labs, INC.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$1.7M Cash on Hand

1.8mo Cash Runway

Follow VIVS by email Get an email when VIVS pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about VIVS, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

VIVS holds $1.7M in cash and short-term investments (as of Jun 30, 2026) and burns about $2.7M/quarter from operations, an estimated runway of 1.8 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 30 · Moderate

Cash runway 2 months +40
Raised after last reported balance sheet (Jul 2026) -10

Recent financing filings on SEC EDGAR:

Jul 17, 2026 · Private placement (8-K Item 3.02) · 8-K
Dec 28, 2023 · Private placement (8-K Item 3.02) · 8-K

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when VIVS files for a raise →

Get the full VIVS picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for VIVS and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z